Blood-brain barrier endothelial tight junction complex (BBB-TJ complex)

The blood-brain barrier (BBB) endothelial tight junction complex is a specialized multi-protein assembly that seals the paracellular space between endothelial cells in the brain's microvasculature. It consists of transmembrane proteins, including claudins (predominantly claudin-5), occludin, and junctional adhesion molecules (JAMs), which interact with cytoplasmic scaffold proteins like zonula occludens (ZO-1, ZO-2, and ZO-3) to link the junction to the actin cytoskeleton (Stamatovic et al., 2016, PubMed: 26826687). This complex is the primary determinant of BBB permeability, creating a high-resistance barrier that protects the central nervous system from toxins and pathogens while maintaining ionic homeostasis (Luissint et al., 2012, PubMed: 23147159). Dysfunction of these complexes is a hallmark of various pathologies, such as stroke and multiple sclerosis, where barrier breakdown exacerbates neurodegeneration (Daneman and Prat, 2015, PubMed: 25560977). In drug development, the complex is targeted either to restore its integrity in disease states or to transiently open it for the delivery of therapeutic agents into the brain (Greene et al., 2019, PubMed: 30733243). Pharmacological modulation can involve osmotic disruption, competitive peptide inhibition, or signaling-mediated reorganization of the junctional proteins (Abbott et al., 2010, PubMed: 20531462).

Other names

Blood-brain barrier tight junctionsEndothelial tight junction complexCerebral microvascular tight junctionsZonula occludens complex

Modulation of paracellular permeability through osmotic cell shrinkage, competitive inhibition of extracellular loops of claudin proteins, or activation of signaling pathways that lead to the phosphorylation and internalization of junctional proteins.